These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 6738577)

  • 1. Increased myofibrillar protein catabolism in duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
    Mussini E; Cornelio F; Colombo L; De Ponte G; Giudici G; Cotellessa L; Marcucci F
    Muscle Nerve; 1984 Jun; 7(5):388-91. PubMed ID: 6738577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
    McKeran RO; Halliday D; Purkiss P
    J Neurol Neurosurg Psychiatry; 1977 Oct; 40(10):979-81. PubMed ID: 591977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Methylhistidine excretion as an index of myofibrillar protein catabolism in neuromuscular disease.
    McKeran RO; Halliday D; Purkiss P; Royston P
    J Neurol Neurosurg Psychiatry; 1979 Jun; 42(6):536-41. PubMed ID: 469561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased turnover of muscle contractile proteins in Duchenne muscular dystrophy as assessed by 3-methylhistidine and creatinine excretion.
    Ballard FJ; Tomas FM; Stern LM
    Clin Sci (Lond); 1979 Apr; 56(4):347-52. PubMed ID: 477220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased rates of myofibrillar protein breakdown in muscle-wasting diseases.
    Warnes DM; Tomas FM; Ballard FJ
    Muscle Nerve; 1981; 4(1):62-6. PubMed ID: 7231447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-methylhistidine excretion in myotonic dystrophy.
    Griggs RC; Moxley RT; Forbes GB
    Neurology; 1980 Dec; 30(12):1262-7. PubMed ID: 7192806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myofibrillar protein degradation in the chicken. 3-Methylhistidine release in vivo and in vitro in normal and genetically muscular-dystrophic chickens.
    Hillgartner FB; Williams AS; Flanders JA; Morin D; Hansen RJ
    Biochem J; 1981 May; 196(2):591-601. PubMed ID: 7316997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown.
    Elia M; Carter A; Bacon S; Winearls CG; Smith R
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):351-4. PubMed ID: 6780020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of 3-methylhistidine and creatine in carriers of Duchenne muscular dystrophy.
    Maskrey P; Harris CI; Milne G; Lane RJ; Pennington RJ
    Clin Chim Acta; 1979 May; 94(1):89-91. PubMed ID: 455721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent changes in the rate of myofibrillar protein degradation in humans as assessed by 3-methylhistidine and creatinine excretion.
    Tomas FM; Ballard FJ; Pope LM
    Clin Sci (Lond); 1979 Apr; 56(4):341-6. PubMed ID: 477219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myofibrillar protein degradation in premature infants with respiratory distress as assessed by 3-methylhistidine and creatinine excretions.
    Lunyong VE; Friedman Z
    Am J Clin Nutr; 1982 Sep; 36(3):485-91. PubMed ID: 7113954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of human myofibrillar protein catabolic rate derived from 3-methylhistidine excretion with synthetic rate from muscle biopsies during L-[alpha-15N]lysine infusion.
    McKeran RO; Halliday D; Purkiss P
    Clin Sci Mol Med; 1978 May; 54(5):471-5. PubMed ID: 750147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary 3-methylhistidine and urinary 3-methylhistidine/creatinine ratio in Duchenne-muscular dystrophy in hemizygotes and in gene-carriers.
    László A; Klujber L
    Acta Paediatr Hung; 1984; 25(4):339-41. PubMed ID: 6525307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myofibrillar protein catabolism in rat steroid myopathy measured by 3-methylhistidine excretion in the urine.
    Shoji S
    J Neurol Sci; 1989 Nov; 93(2-3):333-40. PubMed ID: 2592991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N tau-Methylhistidine excretion and myofibrillar protein breakdown in patients receiving intravenous or enteral nutrition.
    Holbrook IB; Gross E; Milewski PJ; Shipley K; Irving MH
    Clin Sci (Lond); 1980 Sep; 59(3):211-4. PubMed ID: 6775857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease of 3-methylhistidine and increase of NG,NG-dimethylarginine in the urine of patients with muscular dystrophy.
    Inoue R; Miyake M; Kanazawa A; Sato M; Kakimoto Y
    Metabolism; 1979 Aug; 28(8):801-4. PubMed ID: 454517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myofibrillar protein catabolic rates in cirrhotic patients with and without muscle wasting.
    Zoli M; Marchesini G; Dondi C; Bianchi GP; Pisi E
    Clin Sci (Lond); 1982 Jun; 62(6):683-6. PubMed ID: 7083759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Branched-chain ketoacids reduce muscle protein degradation in Duchenne muscular dystrophy.
    Stewart PM; Walser M; Drachman DB
    Muscle Nerve; 1982 Mar; 5(3):197-201. PubMed ID: 7088016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous 3-methylhistidine excretion in healthy women and men with reference to muscle protein metabolism.
    Neuhäuser M; Bässler KH
    Z Ernahrungswiss; 1984 Sep; 23(3):171-80. PubMed ID: 6506809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Content of methylhistidines in normal and pathological human skeletal muscles.
    Mussini E; Cornelio F; Dworzak F; Cotellessa L; Morandi L; Colombo L; De Ponte G; Marcucci F
    Muscle Nerve; 1983; 6(6):423-9. PubMed ID: 6621612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.